Apolipoprotein A1 modifications related to cognitive decline in type 2 diabetes and preclinical alzheimer's disease

Ended Project Grant Awarded Last action

Award ID
W81XWH2210335
Recipient
Awarding agency
Obligated
$712,508

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Cleveland, OH 44195, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Original award $712,508

Subawards

Subrecipient Amount Awarded
Northeast Ohio Medical University The objective of this project is to assess the role of glycated ApoAI on cognitive complications of diabetes. In this collaborative project, I am responsible… $41,707
Northeast Ohio Medical University $40,366

Quick answers

Who received award W81XWH2210335?

W81XWH2210335 was awarded to The Cleveland Clinic Foundation by Defense Health Agency (Department of Defense) on September 1, 2022.

How much is award W81XWH2210335 worth?

$712,508 has been obligated on W81XWH2210335.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login